Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

30 Oct 2015 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated , titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1768.40
Dr. Reddys Labs. 1353.40
Cipla 1383.80
Lupin 2002.95
Zydus Lifesciences 1240.80
View more..